Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHODS OF TREATING LYMPHOCYTIC LEUKEMIA USING INHIBITORS OF BRUTON'S TYROSINE KINASE

  • Read more about METHODS OF TREATING LYMPHOCYTIC LEUKEMIA USING INHIBITORS OF BRUTON'S TYROSINE KINASE
US Application 61/419,764
Filed on 2010-12-03

METHODS OF TREATING ABC-SUBTYPE OF DIFFUSE LARGE B-CELL LYMPHOMA (ABC-DLBCL) USING INHIBITORS OF BRUTON'S TYROSINE KINASE

  • Read more about METHODS OF TREATING ABC-SUBTYPE OF DIFFUSE LARGE B-CELL LYMPHOMA (ABC-DLBCL) USING INHIBITORS OF BRUTON'S TYROSINE KINASE
US Application 61/351,130
Filed on 2010-06-03

Methods And Compositions For Inhibiting Polyomavirus-Associated Pathology

  • Read more about Methods And Compositions For Inhibiting Polyomavirus-Associated Pathology
US Application 61/508,897
Filed on 2011-07-18

Yeast-Brachyury Immunotherapeutic Compositions

  • Read more about Yeast-Brachyury Immunotherapeutic Compositions
US Application 61/453,656
Filed on 2011-03-17

PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC T CELL EPITOPES

  • Read more about PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC T CELL EPITOPES
US Application 61/495,085
Filed on 2011-06-09

Recombinant Immunotoxin Targeting Mesothelin

  • Read more about Recombinant Immunotoxin Targeting Mesothelin
US Application 61/483,531
Filed on 2011-05-06

Reduction of TGF-beta Signaling In Myeloid Cells In The Treatment of Cancer

  • Read more about Reduction of TGF-beta Signaling In Myeloid Cells In The Treatment of Cancer
US Application 61/525,025
Filed on 2011-08-18

Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer

  • Read more about Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
US Application 61/473,409
Filed on 2011-04-08

Design, Generation, And Characterization Of A Monoclonal Antibody Against The NADPH Oxidase 5 (NOX5) Protein

  • Read more about Design, Generation, And Characterization Of A Monoclonal Antibody Against The NADPH Oxidase 5 (NOX5) Protein
US Application 61/471,596
Filed on 2011-04-04

Transient Hypoxia Inducers And Their Use

  • Read more about Transient Hypoxia Inducers And Their Use
US Application 61/478,465
Filed on 2011-04-22

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Page 118
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health